Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | PE(40:4) | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 175 | pmol/sample |
| - | PE(40:4) | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 179 | pmol/sample |
| - | PE(40:4) | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 157 | pmol/sample |
| - | PE(40:4) | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 91.4 | pmol/sample |
| - | PE(40:4) | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 77.7 | pmol/sample |
| - | PE(40:4) | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 82.9 | pmol/sample |
| - | PE(40:4) | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 87.3 | pmol/sample |
| - | PE(40:4) | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 129 | pmol/sample |
| - | PE(40:4) | C | 0.0 | BCD100427B001 | 293 | pmol/sample |
| - | PE(40:4) | C | 0.5 | BCD100427B003 | 127 | pmol/sample |
| - | PE(40:4) | C | 1.0 | BCD100427B007 | 242 | pmol/sample |
| - | PE(40:4) | C | 2.0 | BCD100427B011 | 101 | pmol/sample |
| - | PE(40:4) | C | 4.0 | BCD100427B015 | 117 | pmol/sample |
| - | PE(40:4) | C | 8.0 | BCD100427B019 | 86.5 | pmol/sample |
| - | PE(40:4) | C | 12.0 | BCD100427B023 | 64.7 | pmol/sample |
| - | PE(40:4) | C | 24.0 | BCD100427B027 | 110 | pmol/sample |
| - | PE(40:4) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 107 | pmol/sample |
| - | PE(40:4) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 101 | pmol/sample |
| - | PE(40:4) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 85.6 | pmol/sample |
| - | PE(40:4) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 81 | pmol/sample |
| - | PE(40:4) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 77.5 | pmol/sample |
| - | PE(40:4) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 77.3 | pmol/sample |
| - | PE(40:4) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 165 | pmol/sample |
| - | PE(40:4) | 25OH-Chol | 0.5 | BCD100427B004 | 244 | pmol/sample |
| - | PE(40:4) | 25OH-Chol | 1.0 | BCD100427B008 | 111 | pmol/sample |
| - | PE(40:4) | 25OH-Chol | 2.0 | BCD100427B012 | 216 | pmol/sample |
| - | PE(40:4) | 25OH-Chol | 4.0 | BCD100427B016 | 130 | pmol/sample |
| - | PE(40:4) | 25OH-Chol | 8.0 | BCD100427B020 | 113 | pmol/sample |
| - | PE(40:4) | 25OH-Chol | 12.0 | BCD100427B024 | 95.2 | pmol/sample |
| - | PE(40:4) | 25OH-Chol | 24.0 | BCD100427B028 | 105 | pmol/sample |